Identification of new genetic and immunological biomarkers of severe bronchial asthma as a current problem

Аннотация

There are 300 million asthma sufferers globally, and the mortality rate ranges from 0% to 18%. Worldwide, bronchial asthma (BA), which has a prevalence of 1 to 18 percent, is becoming more common. According to the updated (GINA-2017) definition, asthma is categorized as a diverse airway condition that is typically characterized by persistent airway inflammation. It is characterized by a history of airway blockage and respiratory symptoms such wheezing, shortness of breath, chest congestion, and cough, with variable onset, frequency, and intensity. In recent years, significant and numerous successes in the treatment of bronchial asthma have been achieved.